Eupraxia Pharmaceuticals EPRX SEC Filings

NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Eupraxia Pharmaceuticals Inc. (EPRX) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
16-KCurrent Report0001193125-26-455778Nov 10, 2026 5:25 PM
2SUPPLOthers0001193125-26-455766Nov 10, 2026 5:22 PM
36-KCurrent Report0001171843-26-007334Nov 10, 2026 4:16 PM
46-KCurrent Report0001193125-26-455405Nov 10, 2026 4:04 PM
56-KCurrent Report0001171843-26-007331Nov 10, 2026 4:01 PM
66-KCurrent Report0001171843-26-006756Oct 22, 2026 4:50 PM
76-KCurrent Report0001171843-26-006648Oct 15, 2026 6:13 PM
86-KCurrent Report0001171843-26-006551Oct 9, 2026 4:27 PM
96-KCurrent Report0001171843-26-006307Sep 30, 2026 8:04 AM
106-KCurrent Report0001171843-26-005913Sep 8, 2026 12:05 PM
11SUPPLOthers0001193125-26-379038Sep 2, 2026 12:09 AM
12EFFECTOthers9999999995-26-002742Aug 24, 2026 4:15 AM
13F-10Prospectus0001193125-26-356803Aug 19, 2026 7:34 PM
14SCHEDULE 13GBeneficial Ownership Report0000919574-26-005070Aug 13, 2026 5:03 PM
156-KCurrent Report0001171843-26-005479Aug 13, 2026 12:10 PM
166-KCurrent Report0001193125-26-345045Aug 11, 2026 9:24 PM
17F-XOthers0001193125-26-336190Aug 6, 2026 1:53 AM
18F-10Prospectus0001193125-26-336139Aug 6, 2026 1:11 AM
196-KCurrent Report0001171843-26-004676Jul 15, 2026 5:26 PM
206-KCurrent Report0001171843-26-004605Jul 13, 2026 8:15 PM
216-KCurrent Report0001171843-26-004516Jul 7, 2026 8:20 PM
226-KCurrent Report0001171843-26-004213Jun 22, 2026 3:03 PM
236-KCurrent Report0001171843-26-003787May 29, 2026 6:17 PM
246-KCurrent Report0001171843-26-003785May 29, 2026 6:09 PM
256-KCurrent Report0001171843-26-003762May 28, 2026 8:24 PM
26SCHEDULE 13GBeneficial Ownership Report0000919574-26-002903May 12, 2026 11:04 PM
276-KCurrent Report0001193125-26-219802May 12, 2026 9:06 PM
286-KCurrent Report0001171843-26-003051May 6, 2026 11:00 AM
296-KCurrent Report0001171843-26-003003May 5, 2026 11:00 AM
306-KCurrent Report0001171843-26-002939May 1, 2026 9:23 PM
316-KCurrent Report0001171843-26-002633Apr 22, 2026 11:00 AM
326-KCurrent Report0001171843-26-002597Apr 21, 2026 2:43 PM
336-KCurrent Report0001171843-26-002448Apr 15, 2026 11:12 PM
346-KCurrent Report0001193125-26-155275Apr 15, 2026 10:34 PM
356-KCurrent Report0001171843-26-001612Mar 17, 2026 11:00 AM
36SCHEDULE 13DBeneficial Ownership Report0001193125-26-108982Mar 16, 2026 1:56 AM
3740-FQuarterly & Annual Report0001193125-26-104765Mar 13, 2026 1:18 AM
386-KCurrent Report0001193125-26-096039Mar 6, 2026 6:57 PM
396-KCurrent Report0001171843-26-000978Feb 20, 2026 8:21 PM
40SUPPLOthers0001193125-26-059830Feb 20, 2026 11:19 PM
416-KCurrent Report0001193125-26-059789Feb 20, 2026 10:53 PM
426-KCurrent Report0001171843-26-000911Feb 19, 2026 11:05 AM
43SUPPLOthers0001193125-26-057445Feb 18, 2026 10:13 PM
446-KCurrent Report0001171843-26-000892Feb 18, 2026 10:05 PM
45SCHEDULE 13GBeneficial Ownership Report0000919574-26-001077Feb 17, 2026 4:09 PM
46S-8Prospectus0001193125-26-038116Feb 5, 2026 2:12 AM
476-KCurrent Report0001171843-26-000141Jan 8, 2026 5:02 PM
48SCHEDULE 13GBeneficial Ownership Report0000899140-25-001321Nov 14, 2025 9:37 PM
49SCHEDULE 13GBeneficial Ownership Report0001361974-25-000015Nov 14, 2025 2:10 PM
506-KCurrent Report0001171843-25-007294Nov 13, 2025 10:00 PM

Eupraxia Pharmaceuticals Inc. SEC Filings API

Pull Eupraxia Pharmaceuticals Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=EPRX&formtype=10-K,10-Q&api_key=YOUR_API_KEY